2025-10-07 09:15
Ortivus presents its operations and future market opportunities
Until 10 October, existing and new shareholders have the opportunity to subscribe for shares in Ortivus’ rights issue. To support this decision, the company has prepared the presentation “Care outside the hospital”, in which CEO Gustaf Nordenhök...
THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, OR THE UNITED STATES OF AMERICA...
2025-09-25 08:30
First day of trading in Ortivus' shares without the right to obtain subscription rights regarding the share issue
THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, OR THE UNITED STATES OF AMERICA...
2025-09-24 13:15
Last day for trading in Ortivus's shares including the right to participate in the share issue
THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, OR THE UNITED STATES OF AMERICA...
2025-09-19 16:10
Press release from the Extraordinary General Meeting of Ortivus AB regarding Rights Issue
At the Extraordinary General Meeting of Ortivus AB (publ), held in Danderyd on 19 September 2025, the following resolutions were adopted.
2025-09-09 08:30
Ortivus announces intended allocation of proceeds from the proposed rights issue following agreement with the main shareholder on a new credit facility
Ortivus announced in a press release on 25 August 2025 that the Board of Directors had resolved to propose to an upcoming Extraordinary General Meeting the implementation of a fully guaranteed rights issue of approximately SEK 54 million, with Ortivus’...
2025-08-26 10:15
Ortivus’ Main Shareholder Ponderus Invest AB Extends Credit Facility Agreement with Ortivus
Following the publication yesterday of Ortivus’ interim report for the period 1 January – 30 June 2025, the company’s main shareholder, Ponderus Invest, has resolved to extend the existing credit facility to Ortivus by an additional SEK 10 million...
The shareholders of Ortivus AB (publ), company registration number 556259-1205, are hereby invited to an Extraordinary General Meeting to be held on Friday, 19 September 2025 at 15:00 CET. The meeting will take place at the Company’s premises, Svärdvägen...
A significant impact for the patient and for the healthcare system as a whole, including its costs.
2025-08-25 08:25
The Board of Directors of Ortivus AB proposes a fully underwritten rights issue of approximately SEK 54 million
MUST NOT BE PUBLISHED, DISTRIBUTED OR RELEASED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, RUSSIA, SOUTH AFRICA, OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION...